Martín Gabay

Liposome-based targeting of dopamine to the brain: a novel approach for the treatment of Parkinson’s disease

Meygal Kahana, Abraham Weizman, Martín Gabay et al. · Molecular Psychiatry · 2020 · 68 citations

Neurodegenerative Diseases, Drug Targeting, Liposome-based Targeting +9

Optimization of Antitrypanosomatid Agents: Identification of Nonmutagenic Drug Candidates with in Vivo Activity

Guzmán Álvarez, Javier Varela, Pablo Márquez et al. · Journal of Medicinal Chemistry · 2014 · 47 citations · Full text

Bioorganic Chemistry, Antiparasitic Agent, Immunology +21

Identification of a New Amide-Containing Thiazole as a Drug Candidate for Treatment of Chagas' Disease

Guzmán Álvarez, Javier Varela, Eugenia Cruces et al. · Antimicrobial Agents and Chemotherapy · 2014 · 45 citations · Full text

Development of bis-thiazoles as inhibitors of triosephosphate isomerase from Trypanosoma cruzi. Identification of new non-mutagenic agents that are active in vivo

Guzmán Álvarez, Jennyfer Martínez, Javier Varela et al. · European Journal of Medicinal Chemistry · 2015 · 39 citations

Trypanosoma Cruzi, Biochemistry, Antiparasitic Agent +9

Liposomal Carrier Conjugated to APP-Derived Peptide for Brain Cancer Treatment

Martín Gabay, Abraham Weizman, Nidal Zeineh et al. · Cellular and Molecular Neurobiology · 2020 · 30 citations · Full text

Polymer-drug Conjugate, Medicine, Peptide Engineering +6